Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
20
Mar |
Increased Polyp Detection Rates With Third Eye RetroscopeCategory: Colorectal Cancer | Leave a Comment |
Two new studies show an increase in polyp detection rates using the Third Eye Retroscope (TER), a retrograde viewing device, during colonoscopy. The first study found that TER added to standard colonoscopy detected 13.2 percent more polyps than colonoscopy alone, including 11 percent additional adenomas (precancerous polyps)…
|
20
Mar |
Increased Polyp Detection Rates With Third Eye RetroscopeCategory: Colorectal Cancer | Leave a Comment |
Two new studies show an increase in polyp detection rates using the Third Eye Retroscope (TER), a retrograde viewing device, during colonoscopy. The first study found that TER added to standard colonoscopy detected 13.2 percent more polyps than colonoscopy alone, including 11 percent additional adenomas (precancerous polyps)…
|
12
Jan |
Quest Diagnostics Introduces Molecular Blood Test For Aiding Colorectal Cancer DetectionCategory: Colorectal Cancer | Leave a Comment |
A new blood test that identifies changes in DNA associated with colorectal cancer is now available in the U.S. through Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading cancer diagnostics company. The test is designed to aid the detection of colorectal cancer, the third leading cause of cancer-related deaths…
|
17
Dec |
Researchers Announce Medical Breakthrough With Simple, Inexpensive Blood Test For Colon CancerCategory: Colorectal Cancer | Leave a Comment |
Medical researchers with EDP Biotech Corporation (EDP) have captured national attention with their revolutionary new technology for a simple blood test to detect early-stage colon cancer. Following the success of its pre-clinical trials for the ColoMarker(TM) assay, EDP has filed a patent on the biomarker, CA11-19, and all aspects of its use…
|
17
Dec |
Researchers Announce Medical Breakthrough With Simple, Inexpensive Blood Test For Colon CancerCategory: Colorectal Cancer | Leave a Comment |
Medical researchers with EDP Biotech Corporation (EDP) have captured national attention with their revolutionary new technology for a simple blood test to detect early-stage colon cancer. Following the success of its pre-clinical trials for the ColoMarker(TM) assay, EDP has filed a patent on the biomarker, CA11-19, and all aspects of its use…
|
3
Dec |
Colorectal Cancer: New CRC Screening Combination Increases Detection By 10 PercentCategory: Colorectal Cancer | Leave a Comment |
The combination of sigmoidoscopy and fecal immunochemical test (FIT) detects advanced proximal (right-sided) tumors better than either test alone, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. African Americans, the elderly and women have a higher incidence of proximal colon tumors…
|
3
Dec |
World First: Rectal Tumor Removed Through Anus, Avoiding Painful Abdominal IncisionsCategory: Colorectal Cancer | Leave a Comment |
The world’s first patient to have a malignant rectal tumor removed through the anus, thus avoiding painful abdominal incisions, was a 76-year old woman who was able to leave the Barcelona hospital where she was treated 5 days later, with no complications, and is said to be making an excellent recovery…
|
17
Aug |
Researchers Develop New, More-sensitive Assay For Detecting DNA Methylation In Colon CancerCategory: Colorectal Cancer | Leave a Comment |
A study published in the online issue of Nature Biotechnology, demonstrates a unique and highly sensitive method for detecting methylation-associated cancers. Chemical modification of DNA via the addition or deletion of methyl groups has been established as a common biological means of activating or silencing genes.
|
28
Jul |
64% Of Total Polyps Detected By Conventional Colonoscopy Are Diagnosed By Minimally Invasive Colon Capsule EndoscopyCategory: Colorectal Cancer | Leave a Comment |
Capsule endoscopy for exploring the colon in a minimally invasive manner diagnoses 64% of all lesions located by means of conventional colonoscopy.
|
23
Jul |
Rush University Medical Center Performs First Colorectal Surgeries In The U.S. Using Prosurgics’ FreeHand Laparoscopic Camera ControllerCategory: Colorectal Cancer | Leave a Comment |
Rush University Medical Center and surgical robotics company Prosurgics announce the completion of the first colorectal surgeries in the U.S. using the FreeHand® laparoscopic camera controller. Surgeons Dr. Marc Brand and Dr. Theodore Saclarides of Rush University Medical Center in Chicago successfully completed three laparoscopic hemi-colectomies using the laparoscopic camera controller.